There is no such thing as a biocompatible material

Biomaterials

Volumn 35, Issue 38, 2014, Pages 10009-10014

  Williams, David F ^a,b,c,d,e,f  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c TSINGHUA UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Biocompatibility; Host response; Immunity; Inflammation; Pathways; Toxicity

Indexed keywords

SEMANTICS; TISSUE; TOXICITY;

BIO-COMPATIBLE SYSTEMS; CLINICAL PERFORMANCE; HOST RESPONSE; IMMUNITY; INFLAMMATION; PATHWAYS; REGULATORY SUBMISSIONS; TISSUE COMPONENTS;

BIOCOMPATIBILITY;

BIOMATERIAL;

ACCURACY; ARTICLE; BIOCOMPATIBILITY; COMPREHENSION; CONCEPT ANALYSIS; HOST; HUMAN; IMMUNE RESPONSE; INTRINSICALLY BIOCOMPATIBLE SYSTEM; NOMENCLATURE; OUTCOME ASSESSMENT; SCIENTIFIC LITERATURE; SEMANTICS; CLASSIFICATION; MATERIALS TESTING; PROCEDURES; TOXICITY TESTING;

BIOCOMPATIBLE MATERIALS; MATERIALS TESTING; TERMINOLOGY AS TOPIC; TOXICITY TESTS;

EID: 84908102077     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.08.035     Document Type: Article

References (29)

1. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
2. Charnley J. Tissue reaction to the polytetrafluoroethylene. Lancet 1963, II:1379.
3. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
4. Williams D.F. The biomaterials conundrum in tissue engineering. Tissue Eng Part A 2014, 20:1129-1131.
5. Tang Y., Han S., Liu H., Chen X., Huang L., Li X., et al. The role of surface chemistry in determining invivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials 2013, 34:8741-8755.
6. Ge Z., Chen Q., Osada K., Liu X., Tockary T.A., Uchida S., et al. Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors. Biomaterials 2014, 35:3416-3426.
7. Williams D.F. Concepts in biocompatibility: new biomaterials, new paradigms and new testing regimes. Biocompatibility and performance of medical devices 2012, Woodhead Publishing, London. J.-P. Boutrand (Ed.).
8. Williams D.F. Essential biomaterials science 2014, Cambridge University Press.
9. Baskin J., Pui C.-H., Reiss U., Wilimas J., Metzger M., Ribeiro R., et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009, 374:159-169.
10. Wilson C.J., Clegg R.E., Leavesley D.I., Pearcy M.J. Mediation of biomaterial-cell interactions by adsorbed proteins; a review. Tissue Eng 2005, 11:1-18.
11. Park J.H., Olivares-Navarrete R., Wasilewski C.E., Boyan B., Tannenbaum R., Schwartz Z. Use of polyelectrolyte thin films to modulate osteoblast response to microstructured titanium surfaces. Biomaterials 2012, 33:5267-5277.
12. Ghaedi M., Mendez J.J., Bove P.F., Sivarapatna A., Raredon M.S.B., Niklason L.E. Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. Biomaterials 2014, 32:699-710.
13. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003, 2:347-360.
14. Mitchell R.N. Graft vascular disease: immune response meets the vessel wall. Ann Rev Path Mech Disease 2009, 4:19-47.
15. Eckes B., Zigrino P., Kessler D., Holtkotter O., Shepard P., Mauch M., et al. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000, 19:325-332.
16. Costa D.O., Prowse P.D.H., Chrones T., Sims S.M., Hamilton D.W., Rizkalla A.S., et al. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings. Biomaterials 2013, 34:2715-2726.
17. Wang S., Zhao J., Zhang W., Ye D., Yu W., Zhu C., et al. Maintenance of phenotype and function of cryopreserved bone-derived cells. Biomaterials 2011, 32:3739-3749.
18. Chowdhury F., Na S., Li D., Poh Y.-C., Tanaka T.S., Wang F., et al. Material properties of the cell dictate stress-induced spreading and differentiation in embryonic stem cells. Nat Mater 2010, 9:82-88.
19. Lammers T., Kiessling F., Hennink W.E., Storm G. Drug targeting to tumors: principles, pitfalls and pre-clinical progress. JControl Release 2012, 161:175-187.
20. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2009, 109:259-302.
21. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering; general approaches and a review of recent developments. JR Soc Interface 2011, 8:153-170.
22. Ben-David D., Srouji S., Shapira-Schweitzer K., Kossover O., Ivanir E., Kuhn G., et al. Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. Biomaterials 2013, 34:2902-2910.
23. Moller P., Jacobsen N.R., Folkmann J.K., Danielsen P.H., Mikkelsen L., Hemmingsen J.G., et al. Role of oxidative damage in toxicity of particulates. Free Rad Res 2010, 44:1-46.
24. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immuomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
25. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
26. Schoen F. Mechanisms of function and disease of natural and replacement heart valves. Ann Rev Path Mech Disease 2012, 7:161-183.
27. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. JControl Release 2010, 145:182-195.
28. Singh N., Manshian B., Jenkins G.J.S., Griffiths S.M., Williams P.M., Maffeis T.G., et al. NanoGenotoxicology: the DNA damaging potential of engineered nanoparticles. Biomaterials 2009, 30:3891-3914.
29. McBride S.H., Falls T., Knothe Tate M.L. Modulation of stem cell shape and fate; mechanical modulation of cell shape and gene expression. Tissue Eng Part A 2008, 14:1573-1580.